Gibson called for more funds to be allocated for mobile units to care for drug users in the Bronx; Naloxone training for residents and caregivers; and an ...
The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often follows surgery or injuries.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback